• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    格

    格洛斯特皇家医院

    Gloucestershire Royal Hospital,Gloucestershire Hospitals NHS Foundation Trust
    EST. 1914
    1,716论文总数
    5.4万引用总数

    Gloucestershire Royal Hospital is an acute District General Hospital on the Great Western Road in Gloucester operated by the Gloucestershire Hospitals NHS Foundation Trust.

    论文量&引用量时间轴

    机构学者

    论文(1716)

    年份
    起
    –
    止
    排序
    1Spinal Dural Arteriovenous Fistula Missed on 1.5 T MRI: the Value of Dedicated Spinal Vascular Imaging.
    Toni Saad, Amna Farooq, Sam Nightingale, Tarig Abkur
    2026Practical neurology(2026)
    引用
    AI阅读
    加入学术空间
    2Early Pregnancy for the On‐Call Gynaecologist
    Isabella Laws, Georgia Smith,Jackie Ross

    ABSTRACT Key Content Early pregnancy presentations form a large part of unscheduled hospital attendance, with miscarriage affecting one in four pregnancies. The self‐sufficiency of many Early Pregnancy Assessment Units (EPAUs) can reduce exposure for obstetrics and gynaecology doctors to counselling patients and formulating ongoing management plans. Interpreting scan findings and their significance can be difficult when this is not part of a daily workload. Patients are often anxious and providing support whilst navigating diagnostic uncertainty can be challenging. This article reviews the up‐to‐date evidence for managing early pregnancy problems that the on‐call doctor, particularly when working out of hours, may encounter and clarify ultrasound scan terminology to improve confidence when managing these patients. Learning Objectives To improve confidence in counselling early pregnancy patients about the management of pregnancy of unknown location, pregnancy of uncertain viability, miscarriage and confirmed ectopic pregnancy. To understand the significance of ultrasound findings, including normal findings, by gestational age and to convey this information to patients. To understand the impact of early pregnancy concerns on patients and signpost to appropriate support services. Ethical Issues Misdiagnosis of miscarriage. Delayed diagnosis of miscarriage. Variable access to ultrasound (both equipment and trained users) during out‐of‐hours.

    2026The Obstetrician &amp Gynaecologist(2026)
    引用
    AI阅读
    加入学术空间
    3Vulval Melanoma: a Case Series and Audit from a UK Tertiary Referral Centre
    Sophie Constantinou, Louisa Hancox, Emily Davies

    Abstract Vulvovaginal mucosal melanomas (VVMMs) affect 1.6 individuals per million per year. Patients frequently present with advanced disease and have poor outcomes. As VVMMs are rare, there is a paucity of high-quality evidence on which to base treatment strategies. This study aimed to describe the clinical course and outcomes for patients diagnosed with VVMM and audit the service provided in our tertiary referral centre. In total, 18 cases of VVMM were identified from 358 records of patients diagnosed with vulvovaginal cancer between January 2015 and September 2025. Treatment course and patient outcomes were compared with standards set out by Melanoma Focus for ano-uro-genital mucosal melanoma. Fifteen patients (83%) were first assessed in a gynaecology urgent suspected cancer clinic, and 15 (83%) underwent a diagnostic biopsy prior to surgical resection. Seventeen (94%) had invasive disease at presentation and 50% had an initial Breslow thickness ≥ 4 mm. Overall, 78% had features of both melanoma in situ and invasive disease. Lateral margins following excision were involved in 53%, predominantly with in situ disease. When next-generation sequencing was performed, KIT mutations were identified in 17% (n = 2). Most patients underwent staging investigations including computed tomography (CT) of the thorax, abdomen and pelvis, and CT of the head (93%). Adjuvant treatments included dacarbazine chemotherapy (n = 1), radiotherapy (n = 3) and immunotherapy (n = 8). Five (28%) of the 18 patients were deceased at the point of data collection. One-quarter of patients (2 of 8, 25%) who received immunotherapy did not survive, compared with 30% (3 of 10) who did not receive immunotherapy; treatment was frequently limited by adverse effects. No patients underwent formal assessment of the impact of VVMM on their quality of life. This study highlights the critical need for further research into optimal management strategies for VVMM, particularly the impact of molecular profiles and relevance of immunotherapy. Studies into the impact of VVMM on quality of life are urgently required. Our team have developed a local standard operating procedure to improve patient management.

    2026BRITISH JOURNAL OF DERMATOLOGY(2026)
    引用
    AI阅读
    加入学术空间
    4Humanise by Thomas Heatherwick.
    Toni Saad, Charles J S Nye
    2026Practical neurology(2026)
    引用
    AI阅读
    加入学术空间
    5A Rare Case of Pulmonary Arterial Hypertension in a Patient with Breast Cancer Treated with Trastuzumab Emtansine
    Abbie Maggs, Zeyad Elmarzouky, Chrysovalantou Nikolaidou

    Breast cancer is the most common malignancy in women worldwide. A large proportion of breast cancer cases demonstrate human epidermal growth factor receptor 2 (HER2) overexpression. Trastuzumab emtansine (T-DM1) is an established therapy for HER2-positive metastatic breast cancer, though rare but serious adverse effects may occur. We report a 58-year-old woman with HER2-positive metastatic breast cancer who developed progressive exertional dyspnoea while receiving T-DM1. Echocardiography demonstrated right ventricular dilation and dysfunction with elevated pulmonary pressures. Right heart catheterisation confirmed pulmonary arterial hypertension (PAH) with increased pulmonary vascular resistance. Comprehensive evaluation, including computed tomography, pulmonary angiography, and ventilation-perfusion scanning, excluded thromboembolic disease. There was no significant parenchymal lung disease, and left ventricular function was preserved. In the absence of alternative causes and given the temporal relationship with T-DM1 exposure, drug-induced PAH was considered likely. The patient was treated with sildenafil and ambrisentan, resulting in symptomatic and haemodynamic improvement. Concurrent hepatotoxicity also resolved following discontinuation of T-DM1, further supporting a causal association. PAH is a rare complication of HER2-targeted therapies, with limited cases reported. This case highlights the importance of recognising PAH as a potential adverse effect of T-DM1. Clinicians should maintain a high index of suspicion in patients presenting with unexplained dyspnoea or right ventricular dysfunction to enable early diagnosis and appropriate management.

    2026Cureus(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 1716 篇论文

    合作机构(100)

    Cheltenham General Hospital,Gloucestershire Hospitals NHS Foundation Trust合作论文 58
    布里斯托大学合作论文 43
    牛津大学合作论文 35
    克兰菲尔德大学合作论文 33
    南米德医院合作论文 33
    威尔士大学医院合作论文 29
    皇家德文和埃克塞特医院合作论文 28
    伯明翰大学合作论文 27
    曼彻斯特大学合作论文 25
    莱斯特皇家医院合作论文 24

    机构统计